WR-2721 reduces intestinal toxicity from concurrent gemcitabine and radiation treatment

被引：0
|
作者：
Thinh P. Phan
Christopher H. Crane
Nora A. Janjan
Eduord Vrdoljak
Luka Milas
Kathy A. Mason
机构：
[1] The University of Texas M.D. Anderson Cancer Center,Department of Experimental Radiation Oncology
[2] The University of Texas M.D. Anderson Cancer Center,Department of Radiation Oncology
[3] University of Split School of Medicine,Center of Oncology and Radiotherapy
[4] Clinic Hospital,undefined
来源：
International Journal of Pancreatology | 2001年 / 29卷
关键词：
Gemcitabine; WR-2721 (amifostine); radiation damage; radioprotector; pancreatic cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background. The nucleoside analog gemcitabine is a potent radiosensitizer of both tumor and normal mucosa, so severe toxic reactions have resulted from its combination with radiation in some clinical treatment schedules for pancreatic cancer. WR-2721 (amifostine) has been shown to reduce normal tissue toxicity produced from both radiation treatment and some chemotherapeutics. The aim of this study was to determine if WR-2721 can protect the gastrointestinal mucosa from injury by concurrent gemcitabine and radiation treatment.
引用
收藏
页码：19 / 23
页数：4
相关论文
共 50 条
  • [21] USE OF RADIATION WITH OR WITHOUT WR-2721 IN ADVANCED RECTAL-CANCER
    LIU, T
    LIU, Y
    HE, S
    ZHANG, Z
    KLIGERMAN, MM
    CANCER, 1992, 69 (11) : 2820 - 2825
  • [22] WR-2721 INHIBITION OF RADIATION-INDUCED PROSTAGLANDIN EXCRETION IN RATS
    DONLON, M
    STEEL, L
    HELGESON, EA
    WOLFE, WW
    CATRAVAS, GN
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 1985, 47 (02) : 205 - 212
  • [23] MODIFICATION OF THE ORAL RADIATION DEATH SYNDROME WITH COMBINED WR-2721 AND MISONIDAZOLE
    GRIGSBY, P
    MARUYAMA, Y
    BRITISH JOURNAL OF RADIOLOGY, 1981, 54 (647): : 969 - 972
  • [24] MODIFICATION OF THE ORAL RADIATION DEATH SYNDROME WITH COMBINED WR-2721 AND MISONIDAZOLE
    HEWITT, HB
    PORTER, EH
    BRITISH JOURNAL OF RADIOLOGY, 1982, 55 (650): : 168 - 168
  • [25] MODIFICATION OF RADIATION-INDUCED CARCINOGENESIS IN MICE BY MISONIDAZOLE AND WR-2721
    HUNTER, NR
    GUTTENBERGER, R
    MILAS, L
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1992, 22 (04): : 795 - 798
  • [26] MODIFICATION OF ORAL RADIATION DEATH SYNDROME WITH COMBINED WR-2721 AND MISONIDAZOLE
    GRIGSBY, P
    MARUYAMA, Y
    BRITISH JOURNAL OF RADIOLOGY, 1982, 55 (651): : 250 - 251
  • [27] Enhancement of bone marrow radioprotection and reduction of WR-2721 toxicity by Ocimum sanctum
    Ganasoundari, A
    Devi, PU
    Rao, BSS
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1998, 397 (02) : 303 - 312
  • [28] PHARMACOKINETICS OF WR-1065 IN MOUSE-TISSUE FOLLOWING TREATMENT WITH WR-2721
    UTLEY, JF
    SEAVER, N
    NEWTON, GL
    FAHEY, RC
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1984, 10 (09): : 1525 - 1528
  • [29] PROTECTION AND POTENTIATION OF NITROGEN-MUSTARD CYTO-TOXICITY BY WR-2721
    VALERIOTE, F
    TOLEN, S
    CANCER RESEARCH, 1982, 42 (11) : 4330 - 4331
  • [30] INTRALUMENAL GLUTAMINE ALONE AND GLUTAMINE PLUS WR-2721 PROVIDE INTESTINAL RADIOPROTECTION
    FELEMOVICIUS, I
    BONSACK, ME
    BAPTISTA, ML
    HUNTER, BA
    DELANEY, JP
    GASTROENTEROLOGY, 1995, 108 (04) : A1219 - A1219
12345